3 completed, 1 recruiting. 1 Early Phase 1, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow prabotulinumtoxinA-xvfs: new trials by email Literature Review of prabotulinumtoxinA-xvfs trials Research Report on prabotulinumtoxinA-xvfs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BoTox Into the Sternocleidomastoid Muscles (SCM) prabotulinumtoxinA-xvfs - Neck Muscle Issue | Phase 4 | Recruiting | Boston Medical Center | 30 | 2025-05-14 | 2026-08-31 |
| Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture PrabotulinumtoxinA-Xvfs, IncobotulinumtoxinA, saline solution (placebo) - Skin Aging, Skin Wrinkling | Phase 1 | Completed | Kalpna Kay Durairaj, MD, FACS | 20 | 2024-09-03 | 2025-10-21 |
| Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides PrabotulinumtoxinA-Xvfs, OnabotulinumtoxinA - Rhytides | Early Phase 1 | Completed | Lupo Center for Aesthetic and General Dermatology | 10 | 2023-05-01 | 2024-03-13 |
| Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines PrabotulinumtoxinA-Xvfs, OnabotulinumtoxinA - Glabellar Frown Lines | Phase 2 | Completed | Evolus, Inc. | 154 | 2022-03-30 | 2024-09-04 |
Boston Medical Center (1) · Evolus, Inc. (1) · Kalpna Kay Durairaj, MD, FACS (1) · Lupo Center for Aesthetic and General Dermatology (1)
United States (4)
Jeffrey Spiegel, MD (1) · Kalpna K Durairaj, MD (1) · Rui Avelar, MD (1)